Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells.
Saved in:
| Title: | Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. |
|---|---|
| Authors: | Zaffran I; Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Landolina N; Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Gaur P; Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Rovis TL; Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia., Jonjic S; Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia., Mandelboim O; The Lautenberg Center for General and Tumor Immunology, The Hebrew University Hadassah Medical School, IMRIC, Jerusalem, Israel., Singer BB; Institute of Anatomy, Medical Faculty, University Duisburg-Essen, Essen, Germany., Levi-Schaffer F; Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. francescal@ekmd.huji.ac.il. |
| Source: | Cancer gene therapy [Cancer Gene Ther] 2022 Nov; Vol. 29 (11), pp. 1676-1685. Date of Electronic Publication: 2022 Jun 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35681020 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zaffran+I%22">Zaffran I</searchLink>; Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Landolina+N%22">Landolina N</searchLink>; Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Gaur+P%22">Gaur P</searchLink>; Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Rovis+TL%22">Rovis TL</searchLink>; Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.<br /><searchLink fieldCode="AU" term="%22Jonjic+S%22">Jonjic S</searchLink>; Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.<br /><searchLink fieldCode="AU" term="%22Mandelboim+O%22">Mandelboim O</searchLink>; The Lautenberg Center for General and Tumor Immunology, The Hebrew University Hadassah Medical School, IMRIC, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Singer+BB%22">Singer BB</searchLink>; Institute of Anatomy, Medical Faculty, University Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Levi-Schaffer+F%22">Levi-Schaffer F</searchLink>; Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. francescal@ekmd.huji.ac.il. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229432230%22">Cancer gene therapy</searchLink> [Cancer Gene Ther] 2022 Nov; Vol. 29 (11), pp. 1676-1685. <i>Date of Electronic Publication: </i>2022 Jun 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9432230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5500 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209291903%22">09291903 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Gene Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35681020 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41417-022-00486-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1676 Titles: – TitleFull: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zaffran I – PersonEntity: Name: NameFull: Landolina N – PersonEntity: Name: NameFull: Gaur P – PersonEntity: Name: NameFull: Rovis TL – PersonEntity: Name: NameFull: Jonjic S – PersonEntity: Name: NameFull: Mandelboim O – PersonEntity: Name: NameFull: Singer BB – PersonEntity: Name: NameFull: Levi-Schaffer F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2022 Nov Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1476-5500 Numbering: – Type: volume Value: 29 – Type: issue Value: 11 Titles: – TitleFull: Cancer gene therapy Type: main |
| ResultId | 1 |
